Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed

Jing Huang; Guangting Zeng

doi:10.2807/1560-7917.ES.2022.27.13.2200254

Letter Open Access

Like 0

Download

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed
Jing Huang¹ , Guangting Zeng²
View Affiliations Hide Affiliations

Affiliations: ¹ Jianghua Center for Disease Control and Prevention, Yongzhou, China ² The First People’s Hospital of Chenzhou, University of South China, Chenzhou, China

Correspondence:
Guangting Zeng
1090651185 qq.com
View Citation Hide Citation

Citation style for this article: Huang Jing, Zeng Guangting. Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed. Euro Surveill. 2022;27(13):pii=22-00254. https://doi.org/10.2807/1560-7917.ES.2022.27.13.2200254 Received: 21 Mar 2022; Accepted: 24 Mar 2022

Preview this article:

There is no abstract available.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.13.2200254

2022-03-31

2024-04-26

Click here for cited by

http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.13.2200254

Full text loading...

/deliver/fulltext/eurosurveillance/27/13/eurosurv-27-13-5.html?itemId=/content/10.2807/1560-7917.ES.2022.27.13.2200254&mimeType=html&fmt=ahah

References

Fonager J, Bennedbæk M, Bager P, Wohlfahrt J, Ellegaard KM, Ingham AC, et al. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022. Euro Surveill. 2022;27(10)2200181. https://doi.org/10.2807/1560-7917.ES.2022.27.10.2200181 PMID: 35272746
Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J, et al. Virological characteristics of SARS-CoV-2 BA.2 variant. bioRxiv. 2022:2022.02.14.480335. Preprint. https://doi.org/10.1101/2022.02.14.480335
Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, et al. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2. N Engl J Med.2022;386(10):995-8. https://doi.org/10.1056/NEJMc2119407 PMID: 35263535
Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022. . Epub ahead of print. https://doi.org/10.1038/s41586-022-04594-4 PMID: 35240676
Chen J, Wei GW. Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant. Res Sq.2022:23:rs.3.rs-1362445. Preprint.
Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, Mølbak K, Møller CH, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish households. medRxiv. 2022:2022.01.28.22270044. Preprint. https://doi.org/10.1101/2022.01.28.22270044
Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, et al. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 variants. N Engl J Med. 2022. . Epub ahead of print. https://doi.org/10.1056/NEJMc2201849 PMID: 35294809

Submit comment

Comment moderation successfully completed

Submit your article here

Submit an Article

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed

Click here for cited by